Danaher Corporation reported a strong fourth quarter and full year 2020, marked by a 39.0% increase in revenue for the quarter, driven by 15.5% non-GAAP core revenue growth including Cytiva. Net earnings for the quarter were $1.2 billion, or $1.66 per diluted common share, representing a 55.0% year-over-year increase. The company's non-GAAP adjusted diluted net earnings per common share for the quarter were $2.08, a 62.5% increase over the previous year.
Revenues increased 39.0% year-over-year to $6.8 billion.
Net earnings were $1.2 billion, or $1.66 per diluted common share, a 55.0% increase year-over-year.
Non-GAAP adjusted diluted net earnings per common share were $2.08, a 62.5% increase year-over-year.
Non-GAAP core revenue growth was 15.5% including Cytiva.
The Company anticipates that non-GAAP core revenue growth including Cytiva will be in the mid to high-teens range for the first quarter 2021 and in the low-double digit range for the full year 2021.
Visualization of income flow from segment revenue to net income